Literature DB >> 26731257

Association Between Pituitary-Adrenal Axis Dominance Over the Renin-Angiotensin-Aldosterone System and Hypertension.

Makoto Daimon1, Aya Kamba1, Hiroshi Murakami1, Kazuhisa Takahashi1, Hideyuki Otaka1, Koushi Makita1, Miyuki Yanagimachi1, Ken Terui1, Kazunori Kageyama1, Takeshi Nigawara1, Kaori Sawada1, Ippei Takahashi1, Shigeyuki Nakaji1.   

Abstract

CONTEXT: The hypothalamus-pituitary-adrenal (HPA) axis and the renin-angiotensin aldosterone system (RAAS) are well known to be associated with hypertension. However, the extent of the effects is not yet well elucidated in general conditions.
OBJECTIVE: To separately determine the effect of the HPA axis and the RAAS on hypertension in a general population. DESIGN, SETTING, AND PARTICIPANTS: A population-based study of 859 Japanese individuals enrolled in the 2014 Iwaki study and without hypertension or steroid treatment (age, 50.2 ± 14.7 years). MAIN OUTCOME MEASURES: Hypertension prevalence, plasma concentration of aldosterone, ACTH, cortisol, and plasma renin activity.
RESULTS: Principal component (PC) analysis using these four hormones identified two PCs (PC1 and PC2), which represent levels of these hormones as a whole, and dominance between the HPA axis (ACTH and cortisol) and the RAAS (plasma renin activity and plasma concentration of aldosterone), respectively. Association between these PCs and hypertension was significant (PC1, high vs low, odds ratio [OR], 1.48; 95% confidence interval [CI], 1.09-2.02; and PC2, HPA axis vs RAAS dominancy, OR, 2.08; and 95% CI, 1.51-2.85). However, association between the hormone levels as a whole and hypertension became insignificant after adjustment for multiple factors including these PCs together. However, association between the HPA axis dominance and hypertension remained significant even after the adjustment (the HPA axis vs the RAAS, OR, 1.73; 95% CI, 1.20-2.48).
CONCLUSIONS: The HPA axis dominance over the RAAS is significantly associated with hypertension in a Japanese population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26731257     DOI: 10.1210/jc.2015-3568

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Interrelations between Gut Microbiota Composition, Nutrient Intake and Diabetes Status in an Adult Japanese Population.

Authors:  Ayumi Tamura; Masaya Murabayashi; Yuki Nishiya; Satoru Mizushiri; Kiho Hamaura; Ryoma Ito; Shoma Ono; Akihide Terada; Hiroshi Murakami; Jutaro Tanabe; Miyuki Yanagimachi; Itoyo Tokuda; Kaori Sawada; Kazushige Ihara; Makoto Daimon
Journal:  J Clin Med       Date:  2022-06-05       Impact factor: 4.964

2.  Intraindividual Variability of Aldosterone Concentrations in Primary Aldosteronism: Implications for Case Detection.

Authors:  Nicholas Yozamp; Gregory L Hundemer; Marwan Moussa; Jonathan Underhill; Tali Fudim; Barry Sacks; Anand Vaidya
Journal:  Hypertension       Date:  2020-12-07       Impact factor: 10.190

3.  Targeted neurotransmitter metabolomics profiling of oleanolic acid in the treatment of spontaneously hypertensive rats.

Authors:  Ruixue Yu; Wenqing Yang; Dongmei Qi; Lili Gong; Chao Li; Yunlun Li; Haiqiang Jiang
Journal:  RSC Adv       Date:  2019-07-26       Impact factor: 4.036

4.  Variability of Aldosterone Measurements During Adrenal Venous Sampling for Primary Aldosteronism.

Authors:  Nicholas Yozamp; Gregory L Hundemer; Marwan Moussa; Johnathan Underhill; Tali Fudim; Barry Sacks; Anand Vaidya
Journal:  Am J Hypertens       Date:  2021-02-18       Impact factor: 3.080

5.  Association between serum prolactin levels and insulin resistance in non-diabetic men.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Satoru Mizushiri; Sho Osonoi; Masato Yamaichi; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Ippei Takahashi; Shigeyuki Nakaji
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

6.  The rate of change in declining steroid hormones: a new parameter of healthy aging in men?

Authors:  Andreas Walther; Michel Philipp; Niclà Lozza; Ulrike Ehlert
Journal:  Oncotarget       Date:  2016-09-20

7.  Dominance of the hypothalamus-pituitary-adrenal axis over the renin-angiotensin-aldosterone system is a risk factor for decreased insulin secretion.

Authors:  Makoto Daimon; Aya Kamba; Hiroshi Murakami; Satoru Mizushiri; Sho Osonoi; Kota Matsuki; Eri Sato; Jutaro Tanabe; Shinobu Takayasu; Yuki Matsuhashi; Miyuki Yanagimachi; Ken Terui; Kazunori Kageyama; Itoyo Tokuda; Shizuka Kurauchi; Shigeyuki Nakaji
Journal:  Sci Rep       Date:  2017-09-12       Impact factor: 4.379

8.  Resveratrol provides benefits in mice with type II diabetes-induced chronic renal failure through AMPK signaling pathway.

Authors:  Haiyan Guo; Linyun Zhang
Journal:  Exp Ther Med       Date:  2018-05-17       Impact factor: 2.447

9.  Lower serum calcium levels are a risk factor for a decrease in eGFR in a general non-chronic kidney disease population.

Authors:  Satoru Mizushiri; Makoto Daimon; Hiroshi Murakami; Aya Kamba; Sho Osonoi; Masato Yamaichi; Koki Matsumura; Jutaro Tanabe; Yuki Matsuhashi; Miyuki Yanagimachi; Itoyo Tokuda; Shizuka Kurauchi; Kaori Sawada
Journal:  Sci Rep       Date:  2018-09-21       Impact factor: 4.379

10.  Correlation between miRNA target site polymorphisms in the 3' UTR of AVPR1A and the risk of hypertension in the Chinese Han population.

Authors:  Liuping Zhang; Jinwei Liu; Peng Cheng; Fangchao Lv
Journal:  Biosci Rep       Date:  2019-05-14       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.